Detecting Hypercoagulability in Morbidly Obese and Non Obese Parturients Following Cesarean Section Delivery
Thromboelastometry (ROTEM) For Detecting Hypercoagulability in Morbidly Obese and Non Obese Parturients Following Cesarean Section Delivery: An Observational Study
1 other identifier
observational
40
1 country
1
Brief Summary
Investigators hypothesized that the impact of surgery in terms of inducing a hypercoagulable state is more evident in morbidly obese pregnant women as opposed to their non-obese counterparts. The aim of this study is to investigate the change in coagulation status of morbidly obese and non-obese pregnant women following cesarean section delivery using thromboelastometry. This observational study would also make it possible to calculate the sample size for a future prospective controlled clinical trial to compare the incidence of Hypercoagulability in morbidly obese parturients as opposed to their non-obese counterparts. To the best of our knowledge, no other work has been done any in this area.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Nov 2016
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 17, 2016
CompletedFirst Posted
Study publicly available on registry
March 24, 2016
CompletedStudy Start
First participant enrolled
November 15, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
October 30, 2017
CompletedNovember 8, 2018
November 1, 2018
11 months
January 17, 2016
November 7, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Calculated clot strength using EXTEM Maximum Clot Firmness (G value for EXTEM)
"G" value will be calculated according to the formula: (5000xMCF)/100-MCF and expressed as dynes/cm2
8 hours
Secondary Outcomes (5)
EXTEM clotting time and clot formation time in seconds.
8 hours
EXTEM maximum clot firmness in millimeters
8 hours
INTEM clotting time and clot formation time in seconds.
8 hours
INTEM maximum clot firmness in millimeters
8 hours
FIBTEM maximum clot firmness in millimeters
8 hours
Study Arms (2)
morbidly obese pregnant
Term pregnant women with BMI more than 40
non obese pregnant
Term pregnant women with BMI less than 30
Eligibility Criteria
Term pregnant women presenting for elective cesarean section under spinal anaesthesia
You may qualify if:
- pregnant women at term presenting for cesarean section under spinal anaesthesia with BMI less than 30 and more than 40
You may not qualify if:
- Patients with BMI between 30 and 40 BMI
- Patients with a history of past or current thromboembolism.
- Patients with history of liver disease and those on anticoagulant/anti-platelet therapy
- Patients who requires perioperative blood transfusion
- Patients having General anaesthesia
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Corniche Hospital
Abu Dhabi, 3788, United Arab Emirates
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Mohamed Samy Abdel Raheem, FRCA
Consultant Anaesthetist
- PRINCIPAL INVESTIGATOR
Tarek Ansari, FFARCSI
Consultant Anaesthetist
- PRINCIPAL INVESTIGATOR
Waleed Riad, MD
Consultant Anaesthetist
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 17, 2016
First Posted
March 24, 2016
Study Start
November 15, 2016
Primary Completion
September 30, 2017
Study Completion
October 30, 2017
Last Updated
November 8, 2018
Record last verified: 2018-11
Data Sharing
- IPD Sharing
- Will not share
No plan